2,273 research outputs found

    The application of impantable sensors in the musculoskeletal system: a review

    Get PDF
    As the population ages and the incidence of traumatic events rises, there is a growing trend toward the implantation of devices to replace damaged or degenerated tissues in the body. In orthopedic applications, some implants are equipped with sensors to measure internal data and monitor the status of the implant. In recent years, several multi-functional implants have been developed that the clinician can externally control using a smart device. Experts anticipate that these versatile implants could pave the way for the next-generation of technological advancements. This paper provides an introduction to implantable sensors and is structured into three parts. The first section categorizes existing implantable sensors based on their working principles and provides detailed illustrations with examples. The second section introduces the most common materials used in implantable sensors, divided into rigid and flexible materials according to their properties. The third section is the focal point of this article, with implantable orthopedic sensors being classified as joint, spine, or fracture, based on different practical scenarios. The aim of this review is to introduce various implantable orthopedic sensors, compare their different characteristics, and outline the future direction of their development and application

    Biomedical and Pharmacological Applications of Marine Collagen

    Get PDF
    Biomimetic polymers and materials have been widely used in a variety of biomedical and pharmacological applications. Particularly, collagen-based biomaterials have been extensively applied in various biomedical fields, such as scaffolds in tissue engineering. However, there are many challenges associated with the use of mammalian collagen, including the issues of religious constrains, allergic or autoimmune reactions, and the spread of animal diseases. Over the past few decades, marine collagen (MC) has emerged as a promising biomaterial for biomedical and pharmacological applications. Marine organisms are a rich source of structurally novel and biologically active compounds, and to date, many biological components have been isolated from various marine resources. MC offers advantages over mammalian collagen due to its water solubility, low immunogenicity, safety, biocompatibility, antimicrobial activity, functionality, and low production costs. Due to its characteristics and physicobiochemical properties, it has tremendous potential for use as a scaffold biomaterial in tissue engineering and regenerative medicine, in drug delivery systems, and as a therapeutic. In this Special Issue, we encourage submissions related to the recent developments, advancements, trends, challenges, and future perspectives in this new research field. We expect to receive contributions from different areas of multidisciplinary research, including—but not restricted to—extraction, purification, characterization, fabrication, and experimentation of MC, with a particular focus on their biotechnological, biomedical and pharmacological uses

    Effects of municipal smoke-free ordinances on secondhand smoke exposure in the Republic of Korea

    Get PDF
    ObjectiveTo reduce premature deaths due to secondhand smoke (SHS) exposure among non-smokers, the Republic of Korea (ROK) adopted changes to the National Health Promotion Act, which allowed local governments to enact municipal ordinances to strengthen their authority to designate smoke-free areas and levy penalty fines. In this study, we examined national trends in SHS exposure after the introduction of these municipal ordinances at the city level in 2010.MethodsWe used interrupted time series analysis to assess whether the trends of SHS exposure in the workplace and at home, and the primary cigarette smoking rate changed following the policy adjustment in the national legislation in ROK. Population-standardized data for selected variables were retrieved from a nationally representative survey dataset and used to study the policy action’s effectiveness.ResultsFollowing the change in the legislation, SHS exposure in the workplace reversed course from an increasing (18% per year) trend prior to the introduction of these smoke-free ordinances to a decreasing (−10% per year) trend after adoption and enforcement of these laws (β2 = 0.18, p-value = 0.07; β3 = −0.10, p-value = 0.02). SHS exposure at home (β2 = 0.10, p-value = 0.09; β3 = −0.03, p-value = 0.14) and the primary cigarette smoking rate (β2 = 0.03, p-value = 0.10; β3 = 0.008, p-value = 0.15) showed no significant changes in the sampled period. Although analyses stratified by sex showed that the allowance of municipal ordinances resulted in reduced SHS exposure in the workplace for both males and females, they did not affect the primary cigarette smoking rate as much, especially among females.ConclusionStrengthening the role of local governments by giving them the authority to enact and enforce penalties on SHS exposure violation helped ROK to reduce SHS exposure in the workplace. However, smoking behaviors and related activities seemed to shift to less restrictive areas such as on the streets and in apartment hallways, negating some of the effects due to these ordinances. Future studies should investigate how smoke-free policies beyond public places can further reduce the SHS exposure in ROK

    Phosphate-based glass microspheres for bone repair and localised chemotherapy and radiotherapy treatment of bone cancers

    Get PDF
    Phosphate-based glasses (PBGs) are hugely promising materials for bone repair and regeneration as they can be formulated to be compositionally similar to the inorganic component of bone. Alterations to PBG formulations can be made to tailor their degradation rates and subsequent release of biotherapeutic ions to induce cellular responses, such as osteogenesis. In this work, novel invert-PBGs in the series xP2O5·(56-x)CaO·24MgO·20Na2O (mol%), where x is 40, 35, 32.5 and 30, were formulated to contain pyro (Q1) and orthophosphate (Q0) species. These PBGs were then processed into highly porous microspheres (PMS) via a flame spheroidisation process developed within the research group. Compositional and structural analysis using EDX and 31P-MAS NMR analysis revealed significant depolymerisation had occurred with reducing phosphate content, which increased further when PBGs were processed into PMS. A decrease from 50% to 0% of Q2 species and increase from 6% to 35% of Q0 species was observed for the PMS when the phosphate content decreased from 40 to 30 mol%. Ion release studies also revealed up to a 4-fold decrease in cations and an 8-fold decrease in phosphate anions released with decreasing phosphate content. In vitro bioactivity studies revealed that the orthophosphate rich PMS had favourable bioactivity responses after 28 days of immersion in SBF. Indirect and direct cell culture studies confirmed that the PMS were cytocompatible and supported cell growth and proliferation over 7 days of culture. The P30 PMS with ~65% pyro and ~35% ortho phosphate content revealed the most favourable properties and was proposed to be highly suitable for bone repair and regeneration, especially for orthobiologic applications owing to their highly porous morphology. Doxorubicin (DOX) was used as a model drug to assess its loading and release kinetics from porous phosphate-based glass microspheres to ascertain their suitability for localised drug delivery for the treatment of bone cancers. P40 PMS revealed a DOX loading efficiency of 55%, which was significantly greater than P30 PMS at 29.1%. Both P40 and P30 PMS released more DOX in phosphate buffered saline (PBS) at pH 5 as compared to release at pH 7.4. P40 PMS released 57% of DOX at pH 5 over a 48-hour period, whereas P30 PMS only released 15% of DOX. A pH-responsive DOX release in a more acidic environment suggests that the chemotherapeutic delivery and efficacy properties may lead to increased drug release within tumour tissues. Internal radiotherapy has been shown to be an effective treatment modality to destroy cancerous tissues and is usually achieved by the placement of radioactive sources at the tumour site. In this work, a novel processing method was established to combine yttrium oxide (Y2O3) with P40 phosphate glass particles to form uniform, solid microspheres containing very high yttrium levels via our flame spheroidisation process. The 30Y (~15 mol% Y2O3) and 50Y microspheres (~39 mol% Y2O3) had equivalent and superior yttrium content in comparison to clinically available microspheres used for internal radiotherapy (i.e., Therasphere®). The yttrium-containing microspheres formed were shown to be glass-ceramics, with crystalline phases present but with all elements homogenously distributed throughout the microspheres. Increasing yttrium addition resulted in increased durability of the microspheres, with 50Y microspheres revealing a 10-fold decrease in the release rate of some ions compared to P40 solid microspheres. Indirect and direct cell culture studies confirmed that the 30Y and 50Y microspheres were cytocompatible and supported cell growth and proliferation over 7 days of culture. No significant difference was observed in the metabolic and ALP activity for MG63s for both 30Y and 50Y microspheres from both indirect and direct cell culture studies. Yttrium was incorporated into the phosphate-based microspheres at a level that had not previously been achieved or observed from the literature studies and were shown to support bone cell attachment and growth. A high yttrium content could enable more radiation to be delivered per dose of microspheres, resulting in shorter neutron activation times which could prove beneficial for logistical issues associated with transportation of the biomaterials following nuclear activation. The radionuclide holmium-166 (166Ho) which is comparable to yttrium-90 (90Y) in that it emits β-radiation with a similar tissue penetration range and a significantly reduced half-life of 26.8 hours, was also investigated. The beneficial paramagnetic properties and density of 166Ho indicates that 166Ho-doped materials could be visualised through clinical imaging techniques, whilst simultaneously delivering a therapeutic dose of radiation. In this work, solid holmium-containing microspheres were similarly produced via the flame spheroidisation process using holmium oxide (Ho2O3) and P40 phosphate glass particles. The glass-ceramic microspheres produced had equivalent (30H: ~17mol% Ho2O3) and superior (50H: ~30mol% Ho2O3) holmium content in comparison to clinically used yttrium-doped microspheres (i.e. Therasphere®). Analogous to yttrium containing microspheres, elevated holmium content resulted in topographically unique features on the surface of some 50H microspheres. This increased holmium content resulted in significantly reduced ion release rates for all the ions and the holmium-microspheres did not show evidence of bioactivity. However, in vitro indirect and direct cell culture studies demonstrated their cytocompatibility. No significant difference was observed in the metabolic and ALP activity of MG63 cells for 30H and 50H microspheres in both the indirect and direct cell culture methods. This study appears to be the first to demonstrate microspheres containing high levels of holmium content that can also facilitate direct cell growth and proliferation of human osteoblast-like cells. The microspheres developed are therefore hugely promising biomaterials for both drug delivery and internal radiotherapy applications, as well as for promoting bone repair and regeneration at damaged sites. High holmium content could also result in higher specific activity per microsphere to increase radiotherapy delivery whilst also promoting higher visibility via imaging modalities

    Translational Models for Advancement of Regenerative Medicine and Tissue Engineering

    Get PDF
    At the root of each regenerative medicine or tissue engineering breakthrough is a simple goal, to improve quality of healing, thus improving a patient’s quality of life. Each tissue presents its own complexities and limitations to healing, whether it is the scarring nature of tendon healing or the mechanical complexity driving bone regeneration. Preclinical, translational models aim to reflect these complexities and limitations, allowing for effective development and refinement of tissue engineered therapeutics for human use. The following body of work explores several of these translational models, both utilizing them for tissue regenerative therapy development and evaluating the benefits and complications incurred with each model. This work begins with a discussion of the complexity of bone healing and how dysfunction in the mechanical, surgical, and systemic fracture environment can lead to delayed healing and nonunion. A comprehensive review of the advances in preventative and corrective therapeutics for bone nonunion is included next, with specific focuses on mechanical and tissue-engineered technology. Then, this work presents a tissue-engineered application of mesenchymal stem cells in acute tendon injury, highlighting experimentation in cell fate direction in vitro and intralesional mesenchymal stem cell implantation in vivo. Next, this work presents a series of experiments that evaluated and refined a commonly utilized preclinical model of delayed bone healing, the caprine segmental tibial defect stabilized using single locking plate fixation. First, the biomechanical stability of the model was evaluated in vivo using plantar-pressure analysis of gait. Then, the surgical technique was refined through a retrospective analysis of the effects of plate length and position on fixation stability in vitro and in vivo. Finally, the comorbidities of this preclinical model were explored via an analysis of the effect of long-term tibial locking plate fixation on cortical dimensions and density

    Comparative genomics of recent adaptation in Candida pathogens

    Full text link
    [eng] Fungal infections pose a serious health threat, affecting >1,000 million people and causing ~1.5 million deaths each year. The problem is growing due to insufficient diagnostic and therapeutic options, increased number of susceptible patients, expansion of pathogens partly linked to climate change and the rise of antifungal drug resistance. Among other fungal pathogens, Candida species are a major cause of severe hospital-acquired infections, with high mortality in immunocompromised patients. Various Candida pathogens constitute a public health issue, which require further efforts to develop new drugs, optimize currently available treatments and improve diagnostics. Given the high dynamism of Candida genomes, a promising strategy to improve current therapies and diagnostics is to understand the evolutionary mechanisms of adaptation to antifungal drugs and to the human host. Previous work using in vitro evolution, population genomics, selection inferences and Genome Wide Association Studies (GWAS) have partially clarified such recent adaptation, but various open questions remain. In the three research articles that conform this PhD thesis we addressed some of these gaps from the perspective of comparative genomics. First, we addressed methodological issues regarding the analysis of Candida genomes. Studying recent adaptation in these pathogens requires adequate bioinformatic tools for variant calling, filtering and functional annotation. Among other reasons, current methods are suboptimal due to limited accuracy to identify structural variants from short read sequencing data. In addition, there is a need for easy-to-use, reproducible variant calling pipelines. To address these gaps we developed the “personalized Structural Variation detection” pipeline (perSVade), a framework to call, filter and annotate several variant types, including structural variants, directly from reads. PerSVade enables accurate identification of structural variants in any species of interest, such as Candida pathogens. In addition, our tool automatically predicts the structural variant calling accuracy on simulated genomes, which informs about the reliability of the calling process. Furthermore, perSVade can be used to analyze single nucleotide polymorphisms and copy number-variants, so that it facilitates multi-variant, reproducible genomic studies. This tool will likely boost variant analyses in Candida pathogens and beyond. Second, we addressed open questions about recent adaptation in Candida, using perSVade for variant identification. On the one hand, we investigated the evolutionary mechanisms of drug resistance in Candida glabrata. For this, we used a large-scale in vitro evolution experiment to study adaptation to two commonly-used antifungals: fluconazole and anidulafungin. Our results show rapid adaptation to one or both drugs, with moderate fitness costs and through few mutations in a narrow set of genes. In addition, we characterize a novel role of ERG3 mutations in cross-resistance towards fluconazole in anidulafungin-adapted strains. These findings illuminate the mutational paths leading to drug resistance and cross-resistance in Candida pathogens. On the other hand, we reanalyzed ~2,000 public genomes and phenotypes to understand the signs of recent selection and drug resistance in six major Candida species: C. auris, C. glabrata, C. albicans, C. tropicalis, C. parapsilosis and C. orthopsilosis. We found hundreds of genes under recent selection, suggesting that clinical adaptation is diverse and complex. These involve species-specific but also convergently affected processes, such as cell adhesion, which could underlie conserved adaptive mechanisms. In addition, using GWAS we predicted known drivers of antifungal resistance alongside potentially novel players. Furthermore, our analyses reveal an important role of generally-overlooked structural variants, and suggest an unexpected involvement of (para)sexual recombination in the spread of resistance. Taken together, our findings provide novel insights on how Candida pathogens adapt to human-related environments and suggest candidate genes that deserve future attention. In summary, the results of this thesis improve our knowledge about the mechanisms of recent adaptation in Candida pathogens, which may enable improved therapeutic and diagnostic applications.[cat] Les infeccions fúngiques representen una greu amenaça per a la salut, afectant a més de 1.000 milions de persones i causant aproximadament 1,5 milions de morts cada any. El problema està augmentant a causa d’unes opcions terapèutiques i diagnòstiques insuficients, l'increment del nombre de pacients susceptibles, l'expansió dels patògens parcialment vinculada al canvi climàtic i l'augment de la resistència als fàrmacs antifúngics. D’entre diversos fongs patògens, els llevats del gènere Candida són una causa important d'infeccions nosocomials, amb una alta mortalitat en pacients immunodeprimits. Diverses espècies de Candida constitueixen un problema de salut pública, cosa que requereix més esforços per a desenvolupar nous medicaments, optimitzar els tractaments disponibles i millorar els diagnòstics. Tenint en compte el dinamisme genòmic d’aquests patògens, una estratègia prometedora per millorar les teràpies i diagnòstics actuals és comprendre els mecanismes evolutius d'adaptació als fàrmacs antifúngics i a l’hoste humà. Treballs anteriors utilitzant l'evolució in vitro, la genòmica de poblacions, les inferències de selecció i els estudis d'associació de genoma complet (GWAS, per les sigles en anglès) han aclarit parcialment aquesta adaptació recent, però encara hi ha diverses preguntes obertes. En els tres articles que conformen aquesta tesi doctoral, hem abordat algunes d'aquestes preguntes des de la perspectiva de la genòmica comparativa. En primer lloc, hem abordat qüestions metodològiques relatives a l'anàlisi dels genomes de les espècies Candida. L'estudi de l'adaptació recent en aquests patògens requereix eines bioinformàtiques adequades per a la detecció, filtratge i anotació funcional de variants genètiques. Entre altres raons, els mètodes actuals són subòptims a causa de la limitada precisió per identificar variants estructurals a partir de dades de seqüenciació amb lectures curtes. A més, hi ha una necessitat d’eines computacionals per a la detecció de variants que siguin senzilles d'utilitzar i reproduibles. Per abordar aquestes mancances, hem desenvolupat el mètode bioinformàtic "personalized Structural Variation detection" (perSVade), una eina que permet la detecció, filtratge i anotació de diversos tipus de variants, incloent-hi les variants estructurals, directament des de les lectures. PerSVade permet la identificació precisa de les variants estructurals en qualsevol espècie d'interès, com ara els patògens Candida. A més, la nostra eina prediu automàticament la precisió de la detecció d’aquestes variants en genomes simulats, la qual cosa informa sobre la fiabilitat del procés. Finalment, perSVade es pot utilitzar per analitzar altres tipus de variants, com els polimorfismes de nucleòtid únic o els canvis en el nombre de còpies, facilitant així estudis genòmics integrals i reproduibles. Aquesta eina probablement impulsarà les anàlisis genòmiques en els patògens Candida i també en altres espècies. En segon lloc, hem abordat algunes de les preguntes obertes sobre l'adaptació recent en els llevats Candida, utilitzant perSVade per a la identificació de variants. D'una banda, hem investigat els mecanismes evolutius de resistència als fàrmacs antifúngics en Candida glabrata. Per a això, hem utilitzat un experiment d'evolució in vitro a gran escala per estudiar l'adaptació a dos antifúngics comuns: el fluconazol i l’anidulafungina. Els nostres resultats mostren una adaptació ràpida a un o ambdós fàrmacs, amb un cost per al creixement moderat i a través de poques mutacions en un nombre reduït de gens. A més, hem caracteritzat un paper nou de les mutacions en ERG3 en la resistència creuada al fluconazol en soques adaptades a anidulafungina. Aquests descobriments aclareixen els processos mutacionals que condueixen a la resistència als fàrmacs i a la resistència creuada en els patògens Candida. D'altra banda, hem re-analitzat aproximadament 2.000 genomes i fenotips disponibles en repositoris públics per a comprendre els senyals genòmics de selecció recent i de resistència a fàrmacs antifúngics, en sis espècies rellevants de Candida: C. auris, C. glabrata, C. albicans, C. tropicalis, C. parapsilosis i C. orthopsilosis. Hem trobat centenars de gens sota selecció recent, suggerint que l'adaptació clínica és diversa i complexa. Aquests gens estan relacionats amb funcions específiques de cada espècie, però també trobem processos alterats de manera similar en diferents patògens, com per exemple l’adhesió cel·lular, cosa que indica fenòmens d’adaptació conservats. A part, utilitzant GWAS hem predit mecanismes esperats de resistència a antifúngics i també possibles nous factors. A més, les nostres anàlisis revelen un paper important de les variants estructurals, generalment poc estudiades, i suggereixen una implicació inesperada de la recombinació (para)sexual en la propagació de la resistència. En conjunt, els nostres descobriments proporcionen noves perspectives sobre com els patògens Candida s'adapten als entorns humans, i suggereixen gens candidats que mereixen investigacions futures. En resum, els resultats d’aquesta tesi milloren el nostre coneixement sobre els mecanismes d'adaptació recent en els patògens Candida, cosa que pot permetre el disseny de noves teràpies i diagnòstics

    Physicochemical stimuli to enhance the quality of human engineered cartilage: the role of osmolarity and calcium

    Get PDF
    Due to the low regenerative capacity of articular cartilage, regenerative approaches are needed to treat cartilage defects and to restore the function of the tissue in the joint. However, a general drawback of current cartilage replacement tissues is an insufficient deposition of its main molecular components, type II collagen and proteoglycan. As a result, the tissue cannot withstand the demanding mechanical conditions in the joint. Recent studies of our group achieved an acute stimulation of cartilage matrix synthesis by a defined mechanical loading protocol which depended on the tissue’s glycosaminoglycan (GAG)-content and its associated fixed charge density (FCD). However, to what extend mechano-induced physicochemical sub-stimuli contribute to cartilage matrix production remains unclear. Identifying the decisive sub-parameter that contributes to load-induced stimulation of cartilage matrix synthesis would provide an easily applicable stimulus to optimize the quality of cartilage replacement tissues. Due to the essential role of osmotic pressure for cartilage function, hyperosmotic challenge appears as an important sub-parameter of the loading-response. However, the contribution of acute hyperosmotic pressure to cartilage homeostasis is unclear and models that take a cartilage typical FCD into consideration are required. Interestingly, long-term maturation of animal chondrocytes under hyperosmotic conditions enhanced the matrix content of engineered cartilage but this was so far never investigated for human 3D-cultured chondrocytes. Thus, the aim of this this study was to elucidate whether acute hyperosmotic stimulation, as a sub-parameter of mechanical compression, regulates cartilage matrix synthesis in a human engineered cartilage model at low and high FCD. In parallel, it was investigated whether long-term hyperosmotic stimulation can enhance the matrix synthesis and deposition of cartilage replacement tissue. To achieve these aims, human engineered cartilage was pre-matured for 3 or 35 days to develop a cartilage-like matrix of low or high FCD. Acute hyperosmotic stimulation on day 3 and on day 35 for 3 to 24 hours indicated that the known mechano-response markers ERK1/2, p38, NFAT5, FOS and FOSB are also immediate osmo-response markers, irrespective of the FCD content of the tissue. Opposite to previous results from mechanical loading studies, a downregulation of pro-chondrogenic SOX9 protein and BMP pathway activity indicated an anti-chondrogenic effect of short-term hyperosmotic stimulation on chondrocytes. However, this did not lead to changes in cartilage matrix synthesis at low and at high FCD. Thus, although acute hyperosmotic stimulation and mechanical compression partly triggered similar response pathways, short-term hyperosmotic pressure was no major player to influence the regulation of cartilage matrix synthesis. In the context of long-term hyperosmotic stimulation, previous studies suggested a role of the extracellular calcium microenvironment for cartilage matrix synthesis and deposition. Since articular chondrocytes (AC) and mesenchymal stromal cells (MSC) are often used cell types for the design of cartilage replacement tissues, the response of both cell types to long-term hyperosmotic stimulation was investigated using extracellular calcium. Interestingly, the here obtained data revealed that long-term hyperosmotic calcium stimulation for 35 days compromised cartilage matrix formation in AC-based cartilage replacement tissue but promoted the cartilage matrix formation in neocartilage generated from MSC. Investigation of pro- and anti-chondrogenic signaling pathways after long-term calcium stimulation indicated a specific induction of catabolic S100A4 and PTHLH expression in AC. Stimulating AC with recombinant human PTHrP1-34 peptide partly reproduced the calcium-mediated reduction of cartilage matrix deposition, suggesting a role of PTHrP for impaired cartilage matrix formation. Importantly, the inverse regulation of GAG synthesis in AC and MSC-derived chondrocytes was calcium-specific and not caused by general hyperosmotic effects. Long-term extracellular calcium stimulation, therefore, provides a novel means to enhance the cartilage matrix content of MSC-based engineered cartilage whereas such conditions should be avoided during AC neocartilage formation. Overall, this study provides important information on the role of physicochemical stimuli for cartilage matrix formation in human engineered cartilage. It was demonstrated that acute hyperosmotic pressure was no effective stimulus to influence cartilage matrix synthesis, and further studies are now needed to determine the contribution other load-induced sub-parameter for GAG synthesis. Furthermore, this study indicated that long-term high extracellular calcium treatment provides a novel means to enhance the quality of MSC-based cartilage replacement tissue by stimulating GAG synthesis and GAG deposition. For the application in osteochondral tissue engineering approaches, this implies that MSC should be the first choice for cartilage matrix deposition in the vicinity of resorbable calcified bone replacement materials. However, studies are now needed to confirm the here observed effects of soluble extracellular calcium using resorbable bone replacement material as a potential calcium source

    Cardiovascular health: from cardiomyocyte electrostimulation to miRNA detection

    Get PDF
    Current methods of cell culture where electrical stimulation is applied during culture require a wired connection to a power supply to generate an electric field with which to stimulate the cells. This method is intrusive in a lab setting and does not conveniently allow for traditional cell culture techniques during stimulation, hence it is frequently omitted from cell culture protocols. The aim of this work is to demonstrate a novel method of electrical stimulation of cardiomyocytes using wireless bipolar electrochemical techniques. The work describes the design and characterisation of a wireless bipolar electrode and wireless bipolar electrochemical cell to facilitate wireless bipolar electrostimulation. By using a wireless connection more versatile experiments can be conducted on cells in culture while mitigating the contamination risk of a traditional wired stimulation platform. Using a polypyrrole based conducting film doped with fibronectin molecules to facilitate the adherence and growth of cardiomyocytes on the bipolar electrode surface. Cell culture on a conductive film opens the possibility of future applications in electroceuticals by providing a wireless platform to deliver and electric field to cells in culture. Demonstrating cell culture on conductive polymer with the application of electric fields allows for the study of healthy and disease cell populations in the presence of electrical stimuli. Biomarker monitoring during this work is important to characterise and understand the impact of stimuli on the cells in culture. As such, an electrochemical miRNA biosensor was also explored in this work. The assay was based on the detection of miRNA through hydrogen peroxide degradation. The assay was built of screen-printed electrodes as a method to characterise cell cultures. The ability to monitor biomarkers both in vitro and in vivo is important in generating an understanding of disease models and in the development of point-of-care testing capabilities

    Modern meat: the next generation of meat from cells

    Get PDF
    Modern Meat is the first textbook on cultivated meat, with contributions from over 100 experts within the cultivated meat community. The Sections of Modern Meat comprise 5 broad categories of cultivated meat: Context, Impact, Science, Society, and World. The 19 chapters of Modern Meat, spread across these 5 sections, provide detailed entries on cultivated meat. They extensively tour a range of topics including the impact of cultivated meat on humans and animals, the bioprocess of cultivated meat production, how cultivated meat may become a food option in Space and on Mars, and how cultivated meat may impact the economy, culture, and tradition of Asia
    corecore